(Z)-4-(2,5-dimethylanilino)-4-oxobut-2-enoic acid | 31460-30-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (Z)-4-(2,5-dimethylanilino)-4-oxobut-2-enoic acid
• CAS: 31460-30-7
• 化学式: C₁₂H₁₃NO₃
• 分子量: 219.24
• InChiKey: HKRFJIKIGIFHBL-WAYWQWQTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• NOVEL ANILINE DERIVATIVES AND USE THEREOF
  申请人：NEOMICS Co, Ltd.

  公开号：US20140142333A1

  公开（公告）日：2014-05-22

  Aniline derivatives for anticancer treatment including a compound of the Formula 1, or a derivative thereof, as an active ingredient,

  苯胺衍生物用于抗癌治疗，包括作为活性成分的化合物Formula 1或其衍生物。
• MALEIC ACID DERIVATIVE, PRODUCTION METHOD FOR SAME, AND ANTI-CANCER COMPOSITION COMPRISING SAME
  申请人：Medicinal Bioconvergence Research Center

  公开号：US20160152607A1

  公开（公告）日：2016-06-02

  A maleic acid derivative represented by Chemical Formula 1 below or a pharmaceutically acceptable salt thereof: wherein, A is 5- to 7-membered phenyl having a substituent group, or heteroaryl or heterocycloalkyl containing at least one heteroatom selected from the group consisting of N, O, and S and having a substituent group, or 5- to 7-membered phenyl, heteroaryl, or heterocycloalkyl linked to C 1 -C 5 straight- or branched-chain alkyl, wherein the substituent group is unsubstituted, halogen, OH, OR 1 , nitro, nitrile, NH 2 , NHR 1 , NR 1 R 2 COOH, COOR 1 , CONH 2 , CONHR 1 , C 1 -C 5 straight- or branched-chain alkyl, phenyl, heteroaryl, or 5- to 7-membered heterocycloalkyl, where R 1 and R 2 each are C 1 -C 5 straight- or branched-chain alkyl, or phenyl or heteroaryl having a substituent group.

  下面化学式1所示的马来酸衍生物或其药学上可接受的盐：其中，A是带有取代基的5-至7-成员苯基，或含有来自N、O和S组成的群中至少一个杂原子的杂芳基或杂环烷基并带有取代基，或与C1-C5直链或支链烷基连接的5-至7-成员苯基、杂芳基或杂环烷基，其中取代基未取代、卤素、OH、OR1、硝基、腈、NH2、NHR1、NR1R2COOH、COOR1、CONH2、CONHR1、C1-C5直链或支链烷基、苯基、杂芳基或5-至7-成员杂环烷基，其中R1和R2各自是C1-C5直链或支链烷基，或带有取代基的苯基或杂芳基。
• NOVEL MALEIC ACID DERIVATIVE, PRODUCTION METHOD FOR SAME AND ANTI-CANCER COMPOSITION COMPRISING SAME
  申请人：Medicinal Bioconvergence Research Center

  公开号：EP3006428A1

  公开（公告）日：2016-04-13

  The present invention relates to a novel anticancer composition, and more specifically relates to a maleic acid derivative compound of Chemical Formula 1, to a production method for the compound, and to a pharmaceutical composition comprising the compound. The maleic acid derivative of the present invention suppresses the expression of AIMP2-DX2 and hence selectively suppresses the growth of cancer cell lines without acting on normal cells, and thus pharmaceutical compositions containing the maleic acid derivative of the present invention and pharmaceutically acceptable salts thereof as active ingredients can be used to prevent and treat cancer.

  本发明涉及一种新型抗癌组合物，更具体地说，涉及一种化学式1的马来酸衍生物化合物、该化合物的生产方法以及含有该化合物的药物组合物。本发明的马来酸衍生物可抑制 AIMP2-DX2 的表达，从而选择性地抑制癌细胞株的生长，而不作用于正常细胞，因此含有本发明的马来酸衍生物及其药学上可接受的盐类作为活性成分的药物组合物可用于预防和治疗癌症。
• [EN] NOVEL ANILINE DERIVATIVES AND USE THEREOF<br/>[FR] NOUVEAUX DÉRIVÉS DE L'ANILINE ET LEUR UTILISATION
  申请人：MEDICINAL BIOCONVERGENCE RES CT

  公开号：WO2013019093A2

  公开（公告）日：2013-02-07

  The present invention relates a novel aniline derivatives for anticancer and more particularly, it relates a novel aniline derivatives for anticancer comprising compound of the Formula 1 or a derivative thereof as an active ingredient. A compound of the present invention inhibits AIMP2-DX2 which is novel anticancer target and induces apoptosis of cancer cells, thereby being effective in preventing and treating cancer. Therefore, a novel aniline derivatives of the present invention can be used for preventing and treating cancer.